Franzini, A., Baty F., Macovei I. I., Dürr O., Droege C., Betticher D., et al. (2015).  Gene expression signatures predictive of bevacizumab/erlotinib therapeutic benefit in advanced non-squamous non-small cell lung cancer patients (SAKK 19/05 trial). Clinical Cancer Research. clincanres––3135.

• BibTeX

Franzini, A., Dürr O., Baty F., & Brutsche M. (2014).  Tumor-associated stromal gene expression signatures predict therapeutic response to erlotinib/bevacizumab in non-small cell lung cancer (NSCLC). European Respiratory Journal. 44, P821.

• BibTeX